Track topics on Twitter Track topics that are important to you
The post Exelixis initiates Phase III trial of cabozantinib to treat RCC appeared first on Drug Development Technology.
Original Article: Exelixis initiates Phase III trial of cabozantinib to treat RCCNEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...